References

  1. Criado PR, Criado RFJ, Avancini J, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012; 87(3):435-49. PubMed | Google Scholar

  2. Tricia Y, Ting MD. Anticonvulsant hypersensitivity syndrome: Identification and management. Current Treatment Options in Neurology. July 2007;9(4): 243-248. PubMed | Google Scholar

  3. Bocquet H, Boagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity (Drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996 Dec; 15 (4):250-7. PubMed | Google Scholar

  4. Patrice Cacoub, Philippe Musette, Vincent Descamps, et al. The DRESS Syndrome: A Literature Review. Am J Med. 2011 Jul;124(7):588-97. PubMed | Google Scholar

  5. Wang XQ, Lang SY, Shi XB, et al. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population. Seizure. 2012; 19:562-566. PubMed | Google Scholar

  6. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: What is the pathogenesis? Arch Dermatol. 2001;137 (3):357-364. PubMed | Google Scholar

  7. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004; 140( 2):183-188. PubMed | Google Scholar

  8. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clinical and Experimental Dermatology. 2011 Jan; 36 (1): 6-11. PubMed | Google Scholar

  9. Descamps V, Ben-Saïd B,and all. Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol. 2010 Nov; 137(11):703-708. PubMed | Google Scholar

  10. Vélez A, Moreno JC. Toxic epidermal necrolysis treated with N-acetylcysteine. J Am Acad Dermatol. 2002 Mar;46(3):469-470. PubMed | Google Scholar